Oral Abstract Presentation Session 5
Tracks
.
| Saturday, October 4, 2025 |
| 9:00 AM - 11:15 AM |
| Main Plenary Hall - Rooms 8 & 11 |
Overview
Chair:
Samah Babiker
Presenters
Dr Samah Babiker
Paediatric Haematologist
Guy's And St Thomas Nhs Foundation Trust
Session Chairs
Dr Rohan Kolla
Scientific Director, RareD Medical
Novo Nordisk Regional Office, Istanbul, Türkiye
Regional Perceptions of Quality-of-Life among People with Sickle Cell Disease and their Caregivers: LISTEN-Survey Findings
Dr Petros Kountouris
Assistant Professor
The Cyprus Institute of Neurology and Genetics
The Cyprus Haemoglobinopathy Patient Registry
Dr Rutendo Muzambi
Research Associate
Imperial College London
Trends In Hospitalisations For Sickle Cell Disease, Cystic Fibrosis And Haemophilia In England
Dr Minke Rab
Internist-hematologist
Erasmus University Medical Center
Venous thromboembolism in HbSC and sickle cell anemia and associations with hematological and thromboinflammatory parameters
Mr. Kunjan Rana
Data Scientist
Novo Nordisk
Patient-Reported Quality of Life and Biometric Signals: A Real-Time Window into Vaso-occlusive Crisis Risk
Dr Giulia Reggiani
MD, PhD
Università degli Studi Di Padova
Organ Damage since Childhood in Sickle Cell Disease: Evolution and Influence of Disease-modifying Therapies
Prof. Sujit Sheth
Chief of the Division of Pediatric Hematology/Oncology
New York-Presbyterian Hospital-Weill Cornell Medical Center
Real-world safety profile of twice-daily deferiprone for iron overload in patients with thalassemia syndromes
